Cleveland FES Center

What Cleveland FES Center does

The Cleveland FES Center is a trans-disciplinary research consortium headquartered in Cleveland, Ohio, founded in 1991 that translates Functional Electrical Stimulation (FES) and neuromodulation technologies from bench to bedside. It operates as an alliance of six institutional partners — VA Northeast Ohio Healthcare System (Louis Stokes Cleveland VA Medical Center), Syracuse VA Medical Center, MetroHealth System, Case Western Reserve University, University Hospitals of Cleveland, and Cleveland Clinic Neurological Institute — with a multidisciplinary team of 70+ investigators, 17 postdoctoral fellows, 60+ trainees, and 30+ support staff spanning engineers, physicians, and scientists. The Center's core technology is the use of low-level electrical currents to activate or suppress activity in the peripheral and central nervous system, delivered through proprietary implantable electrodes, brain-computer interfaces, deep brain stimulation systems, high-frequency nerve block technology, and the COSMIIC open-source modular implant platform.

The Center's research programs are organized across five domains: Movement Restoration (limb and body movement for SCI and stroke), Autonomic Systems (bladder, bowel, visceral function), Brain Health (DBS for Parkinson's, stroke, TBI, epilepsy), Pain Management (spinal cord stimulation), and Tools & Technology Development. Clinical trials are conducted across spinal cord injury, stroke, Parkinson's disease, amputation, movement disorders, traumatic brain injury, and chronic pain populations through the consortium's clinical infrastructure; the center also operates a barrier-free participant housing facility (Zubizarreta House) in Cleveland. The Center does not sell commercial products; research participation is provided at no charge to volunteers, and revenue derives from VA research grants, federal agencies, and private foundations (including the Craig H. Neilsen Foundation and a $4.5M ReHAB Project donation).

The Center's business model is grant-funded research translation rather than commercial product sales. Technology commercialization occurs through licensing arrangements with spinouts such as Neuros Medical, whose high-frequency nerve block technology (invented by FES investigators) received FDA Breakthrough Device Designation in 2024. Distribution is anchored in the consortium's six clinical sites, with expansion to Syracuse (2024) extending the geographic footprint. The customer base is not patients (who are research volunteers) but rather funding agencies — primarily the VA — which creates a high concentration risk on a single federal sponsor.

Name

Cleveland FES Center

Legal name

Cleveland FES Center

Website

https://fescenter.org

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Cleveland FES Center is a 1991-founded research consortium of six Cleveland and Syracuse institutions that develops and clinically translates functional electrical stimulation (FES) and neuromodulation technologies to restore movement, autonomic function, and pain relief for patients with spinal cord injury, stroke, Parkinson's, and amputation.

Ownership category

akta.pro rank

Product category

Neuromodulation Research

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

akta.pro secondary industries

Spinal Cord Injury Rehabilitation Centers (HLAFAFAM), Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH)

Keywords

• Neuromodulation research
• Functional electrical stimulation
• Neural interface technology
• Clinical trial research
• Neuroprosthetic devices

Headquarters

HQ city

Cleveland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Federal Research Grants and VA Funding: The center receives core support from the VA (Veterans Affairs) healthcare system and federal research grants. The center has received support for over 30 years. Research funding comes from VA Research and Development, federal agencies, and private foundations.
2. Foundation and Private Grants: Funding from private foundations such as the Craig H. Neilsen Foundation, and donations like the $4.5 million ReHAB Project donation. Also receives support through awards and private philanthropy.

Distribution channels3 records

Marketing channels6 records

Core offering

The Cleveland FES Center is a research consortium that conducts Functional Electrical Stimulation (FES) and neuromodulation research, developing implantable neural systems, brain-computer interfaces, and rehabilitation technologies for individuals with spinal cord injuries, stroke, Parkinson's disease, amputation, and other neurological conditions. It delivers this through research programs (Movement Restoration, Autonomic Systems, Brain Health, Pain Management, Tools & Technology) and clinical trials conducted at six consortium partner institutions.

Product overview

Cleveland FES Center is a research consortium, not a commercial product company. It operates as a trans-disciplinary alliance of scientists and clinicians specializing in biomedical and neural research, engineering, medicine, and rehabilitation. The Center's primary 'product' is the advancement of Functional Electrical Stimulation (FES) technology through research programs including Movement Restoration, Autonomic Systems, Brain Health, Pain Management, and Tools & Technology Development. These programs encompass clinical trials for spinal cord injury, stroke, Parkinson's disease, and amputation, as well as fundamental technology development including nerve block applications, deep brain stimulation, microstimulation, and the COSMIIC open-source implantable device system. The Center facilitates research translation from basic science to clinical practice through a consortium of six institutional partners.

Differentiator

Problem solved

Functional benefit

Products and services

• Movement Restoration Research Program FES-based research program focused on restoring limb and body movements for individuals with spinal cord injuries and neurological disorders through electrical stimulation of the nervous system.
• Autonomic Systems Research Program Research program developing devices that use electrical stimulation to restore bladder and bowel function, and regulate internal body and visceral functions lost to spinal cord injury or neurological disorders.
• Brain Health Research Program Research program focused on brain stimulation technologies for treating movement disorders, stroke rehabilitation, traumatic brain injuries, epilepsy, and neuropsychiatric disorders.
• Pain Management Research Program Research program investigating pain management through neuromodulation techniques including spinal cord stimulation for chronic pain treatment.
• Tools & Technology Development Program Development of implantable systems, electrodes, modeling and simulation tools, and rehabilitation approaches complementary to functional electrical stimulation.
• Spinal Cord Injury Clinical Trials Programs Comprehensive clinical trial programs for spinal cord injury including upper extremity function, pelvic health, cough restoration, general neurorecovery, and gait restoration. Available to research volunteers who fit specific study criteria.
• Stroke Rehabilitation Clinical Trials Programs Clinical trials for stroke rehabilitation focusing on upper limb motor defects, gait rehabilitation, and spatial neglect treatment. Available to research volunteers.
• Parkinson's Disease Clinical Trials Programs Research programs including deep brain stimulation for visuomotor function, lower extremity exercise, and treatment of Parkinson's psychosis. Available to research volunteers.
• Amputation & Prosthetics Clinical Trials Programs Clinical trials for upper limb prosthesis evaluation, peripheral interfaces for sensorimotor integration, and proprioceptive hand prosthesis development. Available to research volunteers.
• COSMIIC Implant System Research Program Open source, modular network of implantable devices for walking assistance after spinal cord injury, under investigation in DoD-funded study.

Quantifiable outcome

• 30-year implant recipient success (Jeanette Green honored for 30-year FES implant)
• +2 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Six partnerships are on record, tiered strategic and core.

• Syracuse VA Medical CenterstrategicStrategic or Co-development Partner · 1 January 2024Researchers at Syracuse VA Medical Center Spinal Cord Injury/Disorders Center officially joined in 2024, particularly in connection with research focusing on spinal cord injury and returning functional independence. Programs comprise traditional scientific research, clinical studies and trials on health and wellness conditions important to Veterans.
• Cleveland Clinic Neurological InstitutecoreStrategic or Co-development Partner · 1 January 2017Joined the consortium in 2017. Includes more than 300 medical, surgical, and research specialists dedicated to treating adult and pediatric patients with neurological and psychiatric disorders. Consistently ranked among top 10 in U.S. News & World Report for neurology and neurosurgery.
• University Hospitals of ClevelandcoreStrategic or Co-development Partner · 1 January 2015Joined as consortium member in 2015. Primary medical affiliate of Case Western Reserve University with strong clinical interactions with the VA. UHC Neurological Institute has major capabilities in neurosurgery, neurology, epilepsy, and psychiatry that complement other consortium expertise.
• VA Northeast Ohio Healthcare System (Louis Stokes Cleveland VA Medical Center)coreStrategic or Co-development Partner · 1 January 1991The founding consortium partner providing clinical care to veterans with complications from spinal cord injuries, head injuries, or stroke. Provides significant support for individual research projects and core infrastructure for veteran-relevant research mission. Home to FES Center operations headquarters.
• MetroHealth SystemcoreStrategic or Co-development Partner · 1 January 1991Founding consortium partner providing valuable access to patient care and clinical expertise in Orthopaedics & Orthopaedic Surgery, Neurosciences & Neurosurgery, and Physical Medicine and Rehabilitation through MetroHealth Rehabilitation Institute, ranked #24 in the nation.
• Case Western Reserve UniversitycoreStrategic or Co-development Partner · 1 January 1991Founding consortium partner through School of Engineering and School of Medicine. Enables access to leading academic, clinical, and engineering expertise, facilities, and a rich learning environment for FES research and development.

Scale indicators5 records

Recent moves10 records

Expansion highlights6 records

Emerging players

• Neuralink: Neuralink is developing high-bandwidth implantable brain-computer interfaces with significant venture funding. While the FES Center focuses more on peripheral nerve and spinal cord stimulation, Neuralink's BCI roadmap directly competes for the same investigator talent, grant funding pools, and eventual patient populations.
• Cala Health: Cala Health develops wearable transcutaneous neuromodulation devices (Cala Trio) for essential tremor and Parkinson's symptoms — overlapping the FES Center's movement-disorder and brain-health programs but using a non-invasive delivery mechanism rather than implantable FES.
• Synchron: Synchron is developing a stent-based brain-computer interface for patients with paralysis. Its focus on restoring function for SCI and stroke patients overlaps the FES Center's most active clinical-trial populations, while operating as a well-funded private commercial company.
• Blackrock Neurotech: Blackrock Neurotech is a private neural-interface company building implantable brain-computer-interface platforms for research and clinical applications. Its research-channel business and BCI technology overlap directly with the FES Center's brain-computer-interface and implantable-systems programs.

Broad incumbents

• Boston Scientific: Boston Scientific competes in the same DBS (Vercise) and SCS (WaveWriter) markets as Medtronic and Abbott and serves as another benchmark incumbent whose commercial product portfolios directly overlap the FES Center's core research domains.
• Abbott: Abbott (via St. Jude Medical acquisition) is a major neuromodulation incumbent with FDA-cleared DBS (Infinity) and SCS (Proclaim) product lines. Its commercial scale, sales force, and surgeon-training infrastructure represent the bar any FES-Center-derived therapy must clear to reach standard-of-care status.
• Medtronic: Medtronic is the dominant incumbent in implantable neurostimulation with FDA-cleared DBS (Activa), SCS, and sacral nerve stimulation platforms. The Cleveland FES Center's research directly overlaps Medtronic's DBS and SCS product categories but as a research consortium rather than a commercial product company.

Direct peers

• Neuros Medical: Neuros Medical commercializes the high-frequency nerve block technology invented by FES Center investigators Kilgore and Bhadra at Case Western Reserve. It is the closest commercial analog of the FES Center's nerve-block and neurostimulation pipeline and has already received FDA Breakthrough Device Designation on FES-derived IP.

Others

• North American Neuromodulation Society (NANS): NANS is the professional society for the neuromodulation field and has recognized FES Center investigators with the Engineering Innovator Award. It serves as an ecosystem-level peer connecting the consortium to clinical, industry, and academic neuromodulation communities rather than as a direct competitor.
• Case Western Reserve University – Department of Biomedical Engineering: CWRU's biomedical engineering department is a founding consortium partner and houses many of the FES Center's principal investigators. It represents the academic-engineering backbone of the consortium and a comparable academic neuromodulation research environment elsewhere would be a meaningful institutional peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/clevelandfes
• Facebookfacebook.com/276131069193343
• LinkedInlinkedin.com/company/cleveland-functional-electrical-stimulation-fes-center
• Instagraminstagram.com/Cleveland_FES_Center

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cleveland FES Center